October 5-6, 2023 | Newark, NJ, USA
Session 1:
Enabling greener DS synthetic routes
Host: Dr. Mark Cameron, J-Star |
||
Dr. Fredrik Nordstrom, BI |
||
Dr. Scott Shulze, Merck |
||
Dr. Chengyi Chen, Mirati |
||
Dr. Samir Kulkani, Pfizer |
||
Session 2:
Enabling desired DS quality attributes
Host: Dr. Chonghui Gu, Foghorn |
||
Dr. Dedong Wu , AstraZeneca |
||
Dr. Bo Wang, Biogen |
||
Prof. Rajesh Dave, NJIT |
||
Dr. Haitao Zhang, Sumitomo |
||
Session 3:
Enabling improved DP performance
Host: Prof. Rajesh Dave, NJIT |
||
Dr. Samuel Kyeremateng, Abbvie |
||
Dr. Ashish Punia , Merck |
||
Prof. Ronald Siegel, UMN |
||
Prof. Calvin Sun, UMN |
||
Panel Discussions | ||
Dr. Chengyi Chen , Mirati Prof. Aaron Moment , Prof. Calvin Sun , UMN |
||
Poster Session | ||
|
||
Lab Tour: Integrated DS-DP Development | ||
SPEAKERS (more to be confirmed) Dr. Cheng Yi Chen, Mirati Therapeutics Prof. Rajesh Dave, New Jersey Institute of Technology Dr. Samir Kulkarni, Pfizer Dr. Samuel Kyeremateng, AbbVie Dr. Ashish Punia, Merck & Co. Dr. Scott Shultz, Merck & Co. Prof. Ronald Siegel, University of Minnesota Prof. Calvin Sun, University of Minnesota Dr. Bo Wang, Biogen Dr. Dedong Wu, AstraZeneca Dr. Haitao Zhang, Sumitomo Pharma America |
||
SPONSORS (more to be confirmed) Porton Pharma Solutions Center for Integrated Material Science and Engineering of Pharmaceutical Products (SIMSEPP) Center for Pharma Crystallization / Porton |